Abstract

Experimental microdosimetry measures the energy deposited in a microscopic sensitive volume (SV) by single ionizing particles traversing the SV or passing by. The fundamental advantage of experimental microdosimetry over the computational approach is that the first allows to determine distributions of energy deposition when information on the energy and nature of the charged particles at the point of interest is incomplete or fragmentary. This is almost always the case in radiation protection applications, but discrepancies between the modelled and the actual scenarios should be considered also in radiation therapy. Models for physical reality are always imperfect and rely both on basic input data and on assumptions and simplifications that are necessarily implemented. Furthermore, unintended events due to human errors or machine/system failures can be minimized but cannot be completely avoided.Though in proton radiation therapy (PRT) a constant relative biological effectiveness (RBE) of 1.1 is assumed, there is evidence of an increasing RBE towards the end of the proton penetration depth. Treatment Planning Systems (TPS) that take into account a variable linear energy transfer (LET) or RBE are already available and could be implemented in PRT in the near future. However, while the calculated dose distributions produced by the TPS are routinely verified with ionization chambers as part of the quality assurance program of every radiotherapy center, there is no commercial detector currently available to perform routine verification of the radiation quality, calculated by the TPS through LET or RBE distributions. Verification of calculated LET is required to make sure that a complex robustly optimized plan will be delivered as planned. The scientific community is coming to conclusion that a new domain of Quality Assurance additionally to the physical dose verification is required, and microdosimetry can be the right approach to address that. A first important prerequisite is the repeatability and reproducibility of microdosimetric measurements. This work aims at studying experimentally the repeatability and reproducibility of microdosimetric measurements performed with a miniaturized Tissue Equivalent Proportional Counter (mini-TEPC) in a 62 MeV proton beam. Experiments were carried out within 1 year and without propane gas recharging and by different operators. RBE was also calculated by applying the Loncol’s weighting function r(y) to microdosimetric distributions. Demonstration of reproducibility of measured microdosimetric quantities y¯F, y¯D and RBE10 in 62 MeV proton beam makes this TEPC a possible metrological tool for LET verification in proton therapy. Future characterization will be performed in higher energy proton beams.

Highlights

  • In current proton therapy a fixed relative biological effectiveness (RBE) equal to 1.1 is used to weight the physical dose for all depths of the primary proton range [1]

  • Experimental microdosimetry [8] can be used to validate simulated physical quantities that are descriptive of the radiation quality, in an analogous way as ionization chambers are used to validate the accuracy of Monte Carlo dose calculations, as part of the quality assurance program of every radiotherapy center [9]

  • Bearing in mind the clinical potential of microdosimetry, the main aim of this paper is to study the repeatability and reproducibility of measurements carried out during four measurement runs at the 62 MeV therapeutic proton beam of CATANA with a miniaturized Tissue Equivalent Proportional Counter used in sealed mode without flowing the filling gas and without changing it for 1 year

Read more

Summary

Introduction

In current proton therapy a fixed RBE equal to 1.1 is used to weight the physical dose for all depths of the primary proton range [1]. An increase in RBE has been observed in several biological assays, in correspondence to the LET increase in the last few millimeters of the primary particle range [2,3,4,5] In spite of this radiobiological evidence, there is no quantitative and widely accepted procedure for radiation quality specification in current proton therapy practice. Treatment Planning Systems (TPS) that consider a variable LET or RBE as an optimization strategy are already available and could be implemented in PRT to improve the treatment outcome in the near future In this context, experimental microdosimetry [8] can be used to validate simulated physical quantities that are descriptive of the radiation quality, in an analogous way as ionization chambers are used to validate the accuracy of Monte Carlo dose calculations, as part of the quality assurance program of every radiotherapy center [9]. Standard detectors should be made available to perform routine verification of the radiation quality calculated by the TPS through LET or RBE distributions

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call